Researchers Suggest Congress Focus On 340B Transparency, Eligibility

By Michelle M. Stein / October 18, 2017 at 8:26 PM
Congress should make hospitals report revenue generated by 340B drug discounts and change the criteria that determines which hospitals get those discounts, according to researchers from Vanderbilt University and the University of Chicago. Lawmakers expressed interest in both of those areas at a recent hearing. The drug industry has been lobbying Congress to change the discount program that they say hospitals abuse, and drug makers have pulled 340B into the debate over how to curb rising drug prices. During a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.